Related Experiment Video
Updated: Oct 28, 2025

Animal Models of Depression - Chronic Despair Model CDM
Published on: September 23, 2021
Neuroinflammatory Basis of Depression: Learning From Experimental Models
Ruqayya Afridi1, Kyoungho Suk1,2
1BK21 Plus KNU Biomedical Convergence Program, Department of Pharmacology, School of Medicine, Kyungpook National University, Daegu, South Korea.
Neuroinflammation, involving glial cells and cytokines, contributes to depression. While animal models show promise, human studies yield mixed results, highlighting research gaps in understanding depression
Area of Science:
- Neuroscience
- Immunology
- Psychiatry
Background:
- Depression is linked to neuroinflammation, where non-neuronal cells and immune responses impair brain function.
- Stress in animal models activates glial cells and increases pro-inflammatory cytokines, suggesting sterile inflammation plays a role.
- Microglial activation is implicated in depression, but human study findings are inconsistent.
Purpose of the Study:
- To review recent advancements in understanding the neuroinflammatory mechanisms of depression.
- To discuss the challenges in modeling depression using animal and in vitro systems.
- To explore therapeutic strategies targeting neuroinflammation for depression treatment.
Main Methods:
- Review of preclinical studies on neuroinflammation and depression.
- Analysis of experimental models of depression, including stress paradigms.
- Examination of findings from human studies on neuroinflammation in depression.
Main Results:
- Preclinical data strongly support microglial activation and polarization in depression.
- Significant discrepancies exist between animal model findings and human depression studies.
- Gaps remain in elucidating the precise molecular pathways of neuroinflammation in depression.
Conclusions:
- Neuroinflammation is a key factor in depression's pathophysiology, particularly evident in animal models.
- Translating findings from experimental models to human depression requires addressing significant challenges.
- Targeting neuroinflammation presents a potential therapeutic avenue for depressive disorders.
More Related Videos
05:56Author Spotlight: Establishing a Rodent Model for Investigating Depression Factors in Traditional Mongolian Medicine
Published on: October 27, 2023
06:55An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
Published on: December 2, 2015
Related Concept Videos
Depression: Overview
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...